[DOI] [PubMed] [Google Scholar] 49.Chen P., Poddar R., Tipa E.V., Dibello P.M., Moravec C.D., Robinson K., Green R., Kruger W.D., Garrow T.A., Jacobsen D.W
The impact of BPC 157 on the heart BPC 157 has a significant effect on the heart
This may reflect the absence of effect of DPP-4 on GE or the higher circulating concentrations of GLP-1 observed in PAM carriers may augment the effect of DPP-4i in prolonging the half-life of GLP-1, which may off set the expected GLP-1 resistance [55]
The chronic nature of obesity has led to renewed interest in pharmacotherapy as an adjunct to lifestyle intervention for achieving and maintaining weight loss
Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take GLP-1 medications with the thyroid C-cell tumor boxed warning
& Elias, E